IBOV 174,951.12 ▲ 0.21% IPSA 11,375.68 ▼ 0.66% IPC MEX 66,644.91 ▲ 0.53% MERVAL 3,044,628 ▲ 1.18% COLCAP 2,507.12 ▼ 0.05% BVL PERÚ 60,449.35 ▲ 0.64% USD/BRL5.15▲ 0.05% USD/MXN16.95— 0.00% USD/CLP920.72▲ 0.81% USD/COP3,122▲ 1.92% USD/PEN3.34▼ 0.40% USD/ARS1,514▲ 0.12% USD/UYU40.18▲ 1.55% USD/PYG5,957▲ 0.99% USD/BOB11.50▲ 1.47% USD/DOP58.15▼ 0.27% USD/CRC450.21▲ 2.07% USD/GTQ7.62▲ 2.21% USD/HNL26.82▲ 0.34% USD/NIO36.62▲ 0.09% USD/VES785.05▼ 0.19% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.73▲ 1.10% EUR/BRL6.00▼ 0.10% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 174,951.12 ▲ 0.21% IPSA 11,375.68 ▼ 0.66% IPC MEX 66,644.91 ▲ 0.53% MERVAL 3,044,628 ▲ 1.18% COLCAP 2,507.12 ▼ 0.05% BVL PERÚ 60,449.35 ▲ 0.64% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Wednesday, August 26, 2026

Covid-19 Brazil

Uruguay’s government responds to 18 questions from judiciary on Covid vaccination of children

By · July 7, 2022 · 2 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – After initial diversionary maneuvers by the Uruguayan government, the Department of Public Health shared, as promised, Secretary Daniel Salinas’ responses to Judge Recarey’s questions about the Covid-19 vaccine. The Secretary submitted his answers in writing.

Today, Thursday, the hearing will continue on the appeal of attorney Maximiliano Dentone, who wants to stop the Covid vaccination for children under 13. The judge ruled that Salinas should testify and answer 18 questions about the vaccination.

Asked if he was aware of international reports of deaths and side effects related to vaccines administered in Uruguay, Salinas acknowledged that he was aware of such reports, but reiterated that “no deaths have been recorded in Uruguay as a result of vaccination.”

Daniel Salinas. (Photo internet reproduction)
Daniel Salinas. (Photo internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
Latin American culture, food and life.
Open the full Ask Rio Times →

Regarding children and possible side effects, the minister assured that no “autoimmunity phenomena” related to vaccination have been observed in children between the ages of 5 and 11.

Salinas was also asked if the Uruguayan state had conducted independent studies to verify the safety and efficacy of the vaccines, to which the minister replied in the affirmative, adding that the results of this surveillance – which include vaccine efficacy, prevention of infections, and SARS-Cov-2 severity and mortality – were available on the ministry’s website.

He added that two vaccine safety surveillance strategies are used in Uruguay, one of which is spontaneous and includes the follow-up of reported cases in terms of severity or medical control, and another of which is the “surveillance of the alleged attributable adverse effect of vaccination and immunization (SAIVE)” in children aged 5 to 11 years, whose vaccination campaign began on January 12, “to increase the possibility of detecting possible cases.

Among other questions, the judge asked about the severity of the disease in children, to which the minister replied that 15% of infections occur in children, and although they pass the disease with mild severity, cases can be complicated in children with comorbidities or in children or adolescents with “prolonged covid”.

“The Ministry of Public Health knows exactly the composition of the vaccines against Covid-19 administered in Uruguay,” Salinas answered when asked about the composition of the vaccines, mentioning in relation to their characteristics that each of them exceeds “the 50% efficacy required by the World Health Organization.”

With information from El Observador

Here is the full text of the answers in Spanish
Here is the AI English translation of the full text of the answers

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.